Swift Medical Raises $35 Million Series B to Transform Wound Care Delivery with AI

Ontario Industry Updates
Written By Doriane Rey
Swift Medical.png

Swift Medical, the global leader in digital wound care, announced recently a Series B funding round of $35 million USD. This latest round of funding will help Swift Medical expand their leading market position and scale their digital wound management platform across the care continuum in North America.

Swift Medical is a former OBIO CAAP Company.

Doriane Rey
Previous

Think Research Announces Definitive Agreement to Acquire BioPharma, a Leading Global Clinical Research Organization
Next

Government of Canada launches Jobs and Growth Fund to create jobs and foster economic activity in Canada’s communities